Prospective Comparative Study between Silodosin 8 mg Versus Combination of Tadalafil 5mg and Silodosin 4mgfor treatment of Lower Urinary Tract Symptoms related to Benign Prostatic Hyperplasia | ||
| SVU-International Journal of Medical Sciences | ||
| Article 57, Volume 6, Issue 1, January 2023, Pages 578-583 PDF (313.04 K) | ||
| Document Type: Original research articles | ||
| DOI: 10.21608/svuijm.2021.66651.1116 | ||
| Authors | ||
| Mostafa AbdelRazek; Ahmad Abolyosr; Omar Mohammed; Atef Fathy; Mohammed Talaat* ; Ahmed M. Hassan | ||
| Urology Department, Faculty of Medicine, South Valley University, Qena, Egypt. | ||
| Abstract | ||
| Background:In men, lower urinary tract symptoms (LUTS) are associated with benign prostatichyperplasia (BPH). Therapeutic options aim to relax prostate smooth muscle and/or reduce prostate enlargement. Objectives:To evaluate the efficacy of Silodosin 8 mgalone versus the combinationof Tadalafil 5mg and Silodosin 4 mgfor treatment of LUTS related to BPH. Patients and methods: About 203 patients with LUTS of BPH who completed the study up protocolpresented to our department classified into two groups group A (101 patients) received Silodosin 8 mg, group B (102 patients) received the combination of Tadalafil 5mg and Silodosin 4 mg. All results recorded and analyzed with Statistical Package for Social Science® (SPSS) and Microsoft Excel 2010. Results: The IPSS, QOL, IIEF score, Q-max and PVR showed significantly greater improvement in the combination of Tadalafil 5mg with Silodosin 4mg than monotherapy of Silodosin 8mg. Conclusions:Despite Silodosin 8mg is well-tolerated and effective treatment option in men with LUTS of BPH, butthe combination of tadalafil 5m and Silodosin 4mg is more effective and feasible for these patients. | ||
| Keywords | ||
| LUTS of BPH; Tadalafil 5mg; Silodosin 4mg; Silodosin 8mg | ||
|
Statistics Article View: 812 PDF Download: 198 |
||
